litlas
ログインアカウント作成

Eugene R. Schiff

1972–2024 年に発表

別表記
EUGENE R. SCHIFF
132
論文数
42,137
被引用数
99
h 指数
131
i10 指数

被引用数

Eugene R. Schiff の年別被引用数1967 年: 被引用 1 件1968 年: 被引用 3 件1969 年: 被引用 2 件1970 年: 被引用 3 件1971 年: 被引用 1 件1972 年: 被引用 3 件1973 年: 被引用 3 件1974 年: 被引用 10 件1975 年: 被引用 5 件1976 年: 被引用 8 件1977 年: 被引用 2 件1978 年: 被引用 8 件1979 年: 被引用 11 件1980 年: 被引用 8 件1981 年: 被引用 6 件1982 年: 被引用 4 件1983 年: 被引用 7 件1984 年: 被引用 8 件1985 年: 被引用 11 件1986 年: 被引用 15 件1987 年: 被引用 8 件1988 年: 被引用 9 件1989 年: 被引用 19 件1990 年: 被引用 30 件1991 年: 被引用 50 件1992 年: 被引用 54 件1993 年: 被引用 86 件1994 年: 被引用 85 件1995 年: 被引用 103 件1996 年: 被引用 64 件1997 年: 被引用 137 件1998 年: 被引用 135 件1999 年: 被引用 179 件2000 年: 被引用 264 件2001 年: 被引用 269 件2002 年: 被引用 293 件2003 年: 被引用 327 件2004 年: 被引用 279 件2005 年: 被引用 314 件2006 年: 被引用 307 件2007 年: 被引用 286 件2008 年: 被引用 281 件2009 年: 被引用 237 件2010 年: 被引用 218 件2011 年: 被引用 259 件2012 年: 被引用 291 件2013 年: 被引用 209 件2014 年: 被引用 263 件2015 年: 被引用 336 件2016 年: 被引用 367 件2017 年: 被引用 222 件2018 年: 被引用 193 件2019 年: 被引用 507 件2020 年: 被引用 462 件2021 年: 被引用 329 件2022 年: 被引用 261 件2023 年: 被引用 203 件2024 年: 被引用 251 件2025 年: 被引用 122 件2026 年: 被引用 4 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,878 件、この内訳の 29.8%フランス: 引用元論文 584 件、この内訳の 6%イギリス: 引用元論文 579 件、この内訳の 6%中国: 引用元論文 562 件、この内訳の 5.8%ドイツ: 引用元論文 557 件、この内訳の 5.8%イタリア: 引用元論文 505 件、この内訳の 5.2%日本: 引用元論文 399 件、この内訳の 4.1%カナダ: 引用元論文 340 件、この内訳の 3.5%スペイン: 引用元論文 308 件、この内訳の 3.2%オーストラリア: 引用元論文 300 件、この内訳の 3.1%台湾: 引用元論文 205 件、この内訳の 2.1%オランダ: 引用元論文 172 件、この内訳の 1.8%
0%29.8%その他 23.6%

機関

分野

  • Medicine89%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Immunology and Microbiology2.3%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.5%
  • その他2%

トピック

  • Hepatitis C virus research17%
  • Liver Disease Diagnosis and Treatment14.9%
  • Hepatitis B Virus Studies12%
  • Liver Disease and Transplantation5.7%
  • HIV/AIDS drug development and treatment3.1%
  • Hepatitis Viruses Studies and Epidemiology2.7%
  • その他44.6%

共著者

全論文

検索で開く
  1. Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

    著者: Samer Gawrieh, Mazen Noureddin, Nicole Loo, Rizwana Mohseni, Vivek Awasty, Kenneth Cusi, Kris V. Kowdley, Michelle Lai, Eugene R. Schiff, Dhruvanshu Parmar, Pankaj Patel, Naga Chalasani - Hepatology 2021 被引用: 356

  2. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

    著者: Arie Regev, Mariana Berho, Lennox J. Jeffers, Clara Milikowski, Enrique Molina, Nikolaos Pyrsopoulos, Zheng-Zhou Feng, K. Rajender Reddy, Eugene R. Schiff - The American Journal of Gastroenterology 2002 被引用: 2,071

  3. Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

    著者: Ting‐Tsung Chang, Yun‐Fan Liaw, Shun-Sheng Wu, Eugene R. Schiff, Kwang‐Hyub Han, Ching‐Lung Lai, Rifaat Safadi, Samuel S. Lee, Waldemar Halota, Zachary Goodman, Yun-Chan Chi, Hui Zhang, R. Hindes, Uchenna H. Iloeje, S. P. Beebe, Bruce Kreter - Hepatology 2010 被引用: 988

  4. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients

    著者: Paul J. Pockros, Michael Fuchs, B. Freilich, Eugene R. Schiff, Anita Kohli, Eric Lawitz, Paul Hellstern, Janet Owens‐Grillo, Courtney Van Biene, Reshma Shringarpure, Leigh MacConell, Д. А. Шапиро, David E. Cohen - Liver International 2019 被引用: 158

  5. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

    著者: Marc Bourlière, Stuart C. Gordon, Steven L. Flamm, Curtis Cooper, Alnoor Ramji, Myron J. Tong, Natarajan Ravendhran, Simon C. Ling, Tram T. Tran, Stephen Pianko, Meena B. Bansal, Victor de Lédinghen, Robert H. Hyland, Luisa M. Stamm, Hadas Dvory‐Sobol, Evguenia S. Svarovskaia, Jie Zhang, Kaijiao Huang, G. Mani Subramanian, Diana M. Brainard, John G. McHutchison, Elizabeth C. Verna, Peter Buggisch, Charles Landis, Ziad Younes, Michael P. Curry, Simone I. Strasser, Eugene R. Schiff, K. Rajender Reddy, M.P. Manns, Kris V. Kowdley, Stefan Zeuzem - New England Journal of Medicine 2017 被引用: 565

  6. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

    著者: Michael P. Curry, Jacqueline G. O’Leary, Natalie Bzowej, Andrew J. Muir, Kevin Korenblat, Jonathan M. Fenkel, K. Rajender Reddy, Eric Lawitz, Steven L. Flamm, Thomas D. Schiano, Lewis Teperman, Robert J. Fontana, Eugene R. Schiff, Michael Fried, Brian Doehle, Di An, John McNally, Anu Osinusi, Diana M. Brainard, John G. McHutchison, Robert S. Brown, Michael Charlton - New England Journal of Medicine 2015 被引用: 806

  7. Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease

    著者: Mitchell L. Shiffman, B. Freilich, Raj Vuppalanchi, Kymberly D. Watt, Jean L. Chan, Al Spada, David Hagerty, Eugene R. Schiff - Alimentary Pharmacology & Therapeutics 2018 被引用: 110

  8. Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection

    著者: Man‐Fung Yuen, Kosh Agarwal, Xiaoli Ma, Tuan Nguyen, Eugene R. Schiff, Hie‐Won Hann, Douglas T. Dieterich, Ronald Nahass, James Park, Sing Chan, Steven‐Huy B. Han, Edward Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard J. Colonno, Julie Ma, Steven Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Y. Kwo, Magdy Elkhashab, Tarek Hassanein, Ho Bae, Jacob Lalezari, Scott Fung, Mark Sulkowski - Journal of Hepatology 2022 被引用: 35

  9. Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection

    著者: Mark Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan Nguyen, Eugene R. Schiff, Hie‐Won Hann, Douglas T. Dieterich, Ronald Nahass, James Park, Sing Chan, Steven‐Huy B. Han, Edward Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard J. Colonno, Julie Ma, Steven Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Y. Kwo, Magdy Elkhashab, Tarek Hassanein, Ho Bae, Jacob Lalezari, Scott Fung, Man‐Fung Yuen - Journal of Hepatology 2022 被引用: 41

  10. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

    著者: Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy, Lorenzo Rossaro, David Bernstein, Eric Lawitz, Mitchell L. Shiffman, Eugene R. Schiff, Reem Ghalib, Michael J. Ryan, Vinod K. Rustgi, Mario Chojkier, Robert Herring, Adrian M. Di Bisceglie, Paul J. Pockros, G. Mani Subramanian, Di An, Evguenia S. Svarovskaia, Robert H. Hyland, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, David Pound, Michael Fried - New England Journal of Medicine 2014 被引用: 1,125

  11. Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

    著者: Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley, Eric M. Yoshida, M. Rodríguez‐Torres, Mark Sulkowski, Mitchell L. Shiffman, Eric Lawitz, Gregory T. Everson, Michael Bennett, Eugene R. Schiff, M. Tarek Al-Assi, G. Mani Subramanian, Di An, M. Lin, John McNally, Diana M. Brainard, William T. Symonds, John G. McHutchison, Keyur Patel, Jordan J. Feld, Stephen Pianko, David R. Nelson - New England Journal of Medicine 2013 被引用: 1,082

  12. Hispanics With Primary Biliary Cirrhosis Are More Likely to Have Features of Autoimmune Hepatitis and Reduced Response to Ursodeoxycholic Acid Than Non-Hispanics

    著者: Cynthia Levy, Jahnavi Naik, Christin Giordano, Amar Mandalia, Christopher O’Brien, Kalyan Ram Bhamidimarri, Eugene R. Schiff, Paul Martin - Clinical Gastroenterology and Hepatology 2013 被引用: 76

  13. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

    著者: Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson, Eric Lawitz, Stuart C. Gordon, Eugene R. Schiff, Ronald Nahass, Reem Ghalib, Norman Gitlin, Robert Herring, Jacob Lalezari, Ziad Younes, Paul J. Pockros, Adrian M. Di Bisceglie, Sanjeev Arora, G. Mani Subramanian, Yanni Zhu, Hadas Dvory‐Sobol, Jenny C. Yang, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, Mark Sulkowski, Paul Y. Kwo - New England Journal of Medicine 2014 被引用: 1,307

  14. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

    著者: John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff, Mitchell L. Shiffman, William M. Lee, Vinod K. Rustgi, Zachary Goodman, Mei–Hsiu Ling, Susannah Cort, Janice K. Albrecht - New England Journal of Medicine 1998 被引用: 3,500

  15. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    著者: Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis, Robert S. Brown, Michael Fried, Norah A. Terrault, Jacqueline G. O’Leary, Hugo E. Vargas, Alexander Kuo, Eugene R. Schiff, Mark Sulkowski, Richard Gilroy, Kymberly D. Watt, Kimberly Brown, Paul Y. Kwo, Surakit Pungpapong, Kevin Korenblat, Andrew J. Muir, Lewis Teperman, Robert J. Fontana, Jill Denning, Sarah Arterburn, Hadas Dvory‐Sobol, T. Brandt-Sarif, Phillip S. Pang, John G. McHutchison, K. Rajender Reddy, Nezam H. Afdhal, Princy Kumar, Eugene R. Schiff, Nezam H. Afdhal, R. S. Brown, Michael Fried, Kris V. Kowdley, Norah A. Terrault, Michael Charlton, Paul Y. Kwo, S. Flamm, John R. Lake, Greg Everson, Mark Sulkowski, Michael P. Curry, Rajender Reddy, Lewis Teperman, Hugo E. Vargas, Surakit Pungpapong, Andrew J. Muir, Atif Zaman, Kimberly Brown, Charles Landis, Alexander Kuo, Robert J. Fontana, Jacqueline G. O’Leary, Richard Gilroy, Obaid S. Shaikh, Kevin Korenblat, Richard T. Stravitz, Kymberly D. Watt, Narayanan Menon, James E. Bredfeldt, Carlos Romero‐Marrero - Gastroenterology 2015 被引用: 799

  16. Histological outcome during long-term lamivudine therapy

    著者: Jules L. Dienstag, Robert Goldin, E. Jenny Heathcote, Hie‐Won Hann, Mary Woessner, Sally L. Stephenson, Stephen D. Gardner, DF Gray, Eugene R. Schiff - Gastroenterology 2003 被引用: 728

  17. A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

    著者: Karen L. Lindsay, Christian Trépo, Tobias Heintges, Mitchell L. Shiffman, Stuart C. Gordon, John C. Hoefs, Eugene R. Schiff, Zachary Goodman, Mark Laughlin, Ruji Yao, Janice K. Albrecht - Hepatology 2001 被引用: 665

  18. Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma

    著者: Rossana M. Calderon, Luigi X. Cubeddu, Ronald Goldberg, Eugene R. Schiff - Mayo Clinic Proceedings 2010 被引用: 165

  19. The current economic burden of cirrhosis.

    著者: Guy Neff, Christopher W. Duncan, Eugene R. Schiff - 2011 被引用: 148

  20. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection

    著者: Thomas Tu, William S. Mason, Andrew D. Clouston, Nicholas Shackel, Geoffrey W. McCaughan, Matthew M. Yeh, Eugene R. Schiff, Andrew Ruszkiewicz, J. W. Chen, Hugh Harley, Uwe H. Stroeher, Allison R. Jilbert - Journal of Viral Hepatitis 2015 被引用: 99

  21. Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

    著者: John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman, Andrew J. Muir, Greg Galler, Jonathan McCone, Lisa M. Nyberg, William M. Lee, Reem Ghalib, Eugene R. Schiff, Joseph Galati, Bruce R. Bacon, Mitchell Davis, Pabak Mukhopadhyay, Kenneth Koury, Stephanie Noviello, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, Mark Sulkowski - New England Journal of Medicine 2009 被引用: 1,185

  22. Outcomes of Liver Transplantation in Patients with Cirrhosis due to Nonalcoholic Steatohepatitis Versus Patients with Cirrhosis due to Alcoholic Liver Disease

    著者: Vishal Bhagat, Ayse L. Mindikoglu, Carmine Nudo, Eugene R. Schiff, Andreas G. Tzakis, Arie Regev - Liver Transplantation 2009 被引用: 181

  23. Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

    著者: Ching‐Lung Lai, Jules L. Dienstag, Eugene R. Schiff, Nancy Leung, Mark Atkins, Christine M. Hunt, Nathaniel Brown, Mary Woessner, Richard Boehme, Lynn D. Condreay - Clinical Infectious Diseases 2003 被引用: 637

  24. Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

    著者: Michael P. Curry, Xavier Forns, Raymond T. Chung, Norah A. Terrault, Robert S. Brown, Jonathan M. Fenkel, Fredric D. Gordon, Jacqueline G. O’Leary, Alexander Kuo, Thomas D. Schiano, Gregory T. Everson, Eugene R. Schiff, Alex S. Befeler, Edward Gane, Sammy Saab, John G. McHutchison, G. Mani Subramanian, William T. Symonds, Jill Denning, Lindsay McNair, Sarah Arterburn, Evguenia S. Svarovskaia, Dilip Moonka, Nezam H. Afdhal - Gastroenterology 2014 被引用: 330